These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32705955)

  • 1. Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Mascarenhas AMS; de Almeida RBM; de Araujo Neto MF; Mendes GO; da Cruz JN; Dos Santos CBR; Botura MB; Leite FHA
    J Biomol Struct Dyn; 2021 Oct; 39(16):6021-6030. PubMed ID: 32705955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual binding site and selective acetylcholinesterase inhibitors derived from integrated pharmacophore models and sequential virtual screening.
    Gupta S; Mohan CG
    Biomed Res Int; 2014; 2014():291214. PubMed ID: 25050335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
    Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
    Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein-drug complex.
    Ece A
    J Biomol Struct Dyn; 2020 Feb; 38(2):565-572. PubMed ID: 30806174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors.
    Mozaffarnia S; Teimuri-Mofrad R; Rashidi MR
    Eur J Med Chem; 2020 Apr; 191():112140. PubMed ID: 32088494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of human acetylcholinesterase by xanthine derivatives: in vitro inhibition and molecular modeling investigations.
    Mohamed T; Osman W; Tin G; Rao PP
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4336-41. PubMed ID: 23791077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.
    de Andrade P; Mantoani SP; Gonçalves Nunes PS; Magadán CR; Pérez C; Xavier DJ; Hojo ETS; Campillo NE; Martínez A; Carvalho I
    Bioorg Med Chem; 2019 Mar; 27(6):931-943. PubMed ID: 30765302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
    Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study.
    Maafi N; Pidaný F; Maříková J; Korábečný J; Hulcová D; Kučera T; Schmidt M; Shammari LA; Špulák M; Carmen Catapano M; Mecava M; Prchal L; Kuneš J; Janoušek J; Kohelová E; Jenčo J; Nováková L; Cahlíková L
    Bioorg Med Chem Lett; 2021 Nov; 51():128374. PubMed ID: 34555506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates.
    Ranjan A; Chauhan A; Jindal T
    Environ Toxicol Pharmacol; 2018 Jan; 57():131-140. PubMed ID: 29272792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds.
    Borges NM; Sartori GR; Ribeiro JFR; Rocha JR; Martins JBL; Montanari CA; Gargano R
    J Mol Model; 2018 Jan; 24(1):41. PubMed ID: 29332299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
    Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
    J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.